Eli Lilly Correlations

LLY
 Stock
  

USD 324.71  0.48  0.15%   

The correlation of Eli Lilly is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eli Lilly moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eli Lilly And moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Additionally, see Stocks Correlation.
  
Refresh
The ability to find closely correlated positions to Eli Lilly could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eli Lilly when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eli Lilly - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eli Lilly And to buy it.

Moving together with Eli Lilly

0.67MRKMerck CompanyPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AXPBHC
WMTBHC
JPMTRV
AXPJPM
AXPTRV
AXPCAT
  
High negative correlations   
IBMBHC
WMTIBM
TRVIBM
AXPIBM
JPMIBM
CATIBM

Eli Lilly Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Eli Lilly stock performing well and Eli Lilly company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Eli Lilly's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
BHC 3.39 (0.98)  0.00 (0.71)  0.00 (0.20)  0.00  5.33 (7.40)  32.46 
IBM 1.21  0.27  0.20  0.16  1.41  0.19 (1.27)  2.47 (2.47)  11.05 
TRV 1.15  0.01  0.00 (0.18)  0.00  0.06  0.00  2.01 (2.17)  6.41 
JPM 1.46 (0.10)  0.00 (0.29)  0.00 (0.06)  0.00  2.98 (3.00)  10.78 
CAT 1.74 (0.10)  0.00 (0.29)  0.00 (0.0486)  0.00  3.20 (4.35)  10.92 
VZ 1.07  0.13  0.13  0.06  1.67  0.15 (1.08)  2.30 (2.42)  7.94 
HPQ 2.50  0.01  0.00 (0.19)  0.00 (0.0261)  0.00  4.02 (4.48)  21.74 
AXP 1.90 (0.17)  0.00 (0.32)  0.00 (0.10)  0.00  3.46 (3.99)  9.74 
WMT 1.36 (0.15)  0.00 (0.47)  0.00 (0.0313)  0.00  2.43 (2.47)  13.98 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Eli Lilly without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Eli Lilly Corporate Directors

Eli Lilly corporate directors refer to members of an Eli Lilly board of directors. The board of directors generally takes responsibility for the Eli Lilly's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Eli Lilly's board members must vote for the resolution. The Eli Lilly board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Ralph Alvarez - Independent DirectorProfile
Jamere Jackson - Independent DirectorProfile
Juan Luciano - Lead Independent DirectorProfile
Karen Walker - Independent DirectorProfile

Investing Eli Lilly And

You need to understand the risk of investing before taking a position in Eli Lilly. The danger of trading Eli Lilly And is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Eli Lilly is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Eli Lilly. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Eli Lilly And is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, see Stocks Correlation. Note that the Eli Lilly And information on this page should be used as a complementary analysis to other Eli Lilly's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Eli Lilly Stock analysis

When running Eli Lilly And price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli Lilly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.41
Market Capitalization
308.5 B
Quarterly Revenue Growth YOY
0.15
Return On Assets
0.12
Return On Equity
0.74
The market value of Eli Lilly And is measured differently than its book value, which is the value of Eli Lilly that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine Eli Lilly value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.